Structure Therapeutics Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
GPCR on Nasdaq
Location
611 Gateway Blvd Suite 223, South San Francisco, CA

Insiders trading volume in the past year

Structure Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fmr Llc Other*, 10%+ Owner $47.6M -$1.25K 0% Feb 6, 2025
Ramy Farid Director $17.2M Feb 7, 2023
Raymond C. Stevens CHIEF EXECUTIVE OFFICER, Director $211K -$9.77M -97.9% Mar 15, 2025
Jun Yoon Chief Financial Officer $64.6K Mar 15, 2025
Melita Sun Jung Chief Business Officer $62.5K Feb 7, 2023
Crespo Blas Coll Chief Medical Officer $52.8K Mar 15, 2025
Xichen Lin Chief Scientific Officer $0 -$1.68M -100% Mar 15, 2025
Sharon Tetlow Director Jun 25, 2024
Joanne Waldstreicher Director Jun 25, 2024
Eric Dobmeier Director Jun 25, 2024
Mark Allen Bach Chief Medical Officer Mar 15, 2024
Yingli Ma Chief Technology Officer Mar 15, 2025
Angus C. Russell Director Aug 26, 2024
Ashley Hall Chief Development Officer Mar 15, 2025
Bvf Partners L P/Il 10%+ Owner May 10, 2023
FIL Ltd Other* Feb 7, 2023
Daniel G. Welch Director Jun 25, 2024
Ted W. Love Director Jun 25, 2024

Recent Insider Transactions by Companies or Individuals for Structure Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.